Destruxin B Suppresses Drug-Resistant Colon Tumorigenesis and Stemness Is Associated with the Upregulation of miR-214 and Downregulation of mTOR/β-Catenin Pathway

Background: Drug resistance represents a major challenge for treating patients with colon cancer. Accumulating evidence suggests that Insulin-like growth factor (IGF)-associated signaling promotes colon tumorigenesis and cancer stemness. Therefore, the identification of agents, which can disrupt can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Szu-Yuan, Huang, Yan-Jiun, Tzeng, Yew-Min, Huang, Chi-Ying F., Hsiao, Michael, Wu, Alexander T.H., Huang, Tse-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209980/
https://www.ncbi.nlm.nih.gov/pubmed/30257507
http://dx.doi.org/10.3390/cancers10100353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209980/
https://www.ncbi.nlm.nih.gov/pubmed/30257507
http://dx.doi.org/10.3390/cancers10100353

Ejemplares similares